Impact of SGLT2 inhibitors on cardiovascular outcomes in patients with heart failure with reduced ejection fraction.Published in:Pharmacotherapy, 2021, v. 41, n. 6, p. 526, doi. 10.1002/phar.2527By:Starr, Jessica A.;Pinner, Nathan A.;Lisenby, Katelin M.;Osmonson, AlyssaPublication type:Article